Phosphoinositide 3-kinase signaling is critical for ErbB3-driven breast cancer cell motility and metastasis.
about
Characterisation of HER heterodimers in breast cancer using in situ proximity ligation assayStructure-function relationships of ErbB RTKs in the plasma membrane of living cellsERBB3-mediated regulation of Bergmann glia proliferation in cerebellar lamination.Increased expression of MyD88 and association with paclitaxel resistance in breast cancer.Perhexiline promotes HER3 ablation through receptor internalization and inhibits tumor growth.Repurposing Kinase Inhibitors as Antiviral Agents to Control Influenza A Virus Replication.Metabolic plasticity of metastatic breast cancer cells: adaptation to changes in the microenvironment.Effects of neuregulin-1 administration on neurogenesis in the adult mouse hippocampus, and characterization of immature neurons along the septotemporal axis.The unpluggable in pursuit of the undruggable: tackling the dark matter of the cancer therapeutics universe.HER2/HER3 regulates extracellular acidification and cell migration through MTK1 (MEKK4).miR-139-5p is a regulator of metastatic pathways in breast cancer.Estrogen receptor-positive breast cancer molecular signatures and therapeutic potentials (Review).Fibroblast growth factor receptor 4 (FGFR4) and fibroblast growth factor 19 (FGF19) autocrine enhance breast cancer cells survival.Autocrine HBEGF expression promotes breast cancer intravasation, metastasis and macrophage-independent invasion in vivo.Serpin E2 promotes breast cancer metastasis by remodeling the tumor matrix and polarizing tumor associated macrophages.HER2/HER3 heterodimers and p21 expression are capable of predicting adjuvant trastuzumab response in HER2+ breast cancer.Neuregulin-1 overexpression and Trp53 haploinsufficiency cooperatively promote de novo malignant peripheral nerve sheath tumor pathogenesis.MiR-139-5p: promising biomarker for cancer.Tumor cell intravasation.Combination of antibodies directed against different ErbB3 surface epitopes prevents the establishment of resistance to BRAF/MEK inhibitors in melanoma.Her3 is associated with poor survival of gastric adenocarcinoma: Her3 promotes proliferation, survival and migration of human gastric cancer mediated by PI3K/AKT signaling pathway.Expression of Cox-2 in human breast cancer cells as a critical determinant of epithelial-to-mesenchymal transition and invasiveness.Reverse transendothelial cell migration in inflammation: to help or to hinder?ERBB3 (HER3) is a key sensor in the regulation of ERBB-mediated signaling in both low and high ERBB2 (HER2) expressing cancer cells.Prognostic significance of HER3 in patients with malignant solid tumors.Fatty acid synthase affects expression of ErbB receptors in epithelial to mesenchymal transition of breast cancer cells and invasive ductal carcinoma.Memo is a copper-dependent redox protein with an essential role in migration and metastasis.Matrix-Gla protein promotes osteosarcoma lung metastasis and associates with poor prognosis.SYK inhibition blocks proliferation and migration of glioma cells and modifies the tumor microenvironment.Loss of Anti-HER-3 CD4+ T-Helper Type 1 Immunity Occurs in Breast Tumorigenesis and is Negatively Associated with Outcomes.
P2860
Q24337937-CC002C70-7C58-47EA-9FCD-82F14EACF817Q26853162-F2CAFFC7-0CE2-45B0-943A-20C39DF7866BQ27345740-76717399-CE2A-4F88-9278-7998A0C61C6FQ27853281-6E15B938-24EE-41B4-895C-04756E55D12CQ35174240-DCCEF95F-D4EC-4E9A-801A-2366B3CB82B3Q35698322-C46C9CD8-818B-4865-84F6-BFDDFE9D60C4Q36360129-4FFF2F1A-99FE-4EE1-8E39-0CCF4B6A105AQ37137213-F478B7BD-2376-4B9B-9876-36CADF99BF30Q37385372-768F259C-35AF-49E7-AF69-D66D427B0C3DQ37407344-D4D15315-E052-4F6D-8FE1-A4A4F68B69FFQ37448717-BDFE3B1A-2E0B-4802-BD4C-11F62A3D9F00Q37565213-88C5ABF8-E91B-48F4-BCB4-95E7D0B99965Q37628912-DE6472EA-F17D-4157-AFA8-5E2EAE55C1E6Q37631248-77C21B32-B5D6-4A1F-B74A-AC49DAAFC8F0Q37696118-45CB3F77-2373-4757-9EA4-9234DC4F1CBAQ37699133-275A29F6-ADA3-49D9-8749-91915337A4EBQ37722550-C466544F-CC0E-4CBB-9236-BF5BBCA32BEBQ38359431-A039022A-1464-47B9-B484-771FFFD0B41AQ38807918-396C0893-5440-4A1C-99FF-5A257F7FF040Q38849622-7ABFA2CC-2947-4F6C-A020-A2D6595DAA39Q39016174-5C4DC995-5E1E-481D-B011-7447D065A51BQ39044750-AA1F398B-8910-43D1-A5B9-1A6D9C7954A7Q39057036-23978B22-453A-4317-AA32-7E8EDFD6002CQ39206148-384166C1-1021-46C0-98F6-1EA8CF9F6723Q42148898-F16941F6-CF47-4934-845E-60E441EBDFAEQ43912153-E39BC011-C950-41F2-93DD-755B66C5E109Q46881176-4CEBF7B3-9021-40B2-A49C-9E5C18B80DA2Q50853780-A896932A-03F3-4096-815C-B61D25A10524Q52699628-10799B04-FBA8-456E-931F-DE2DB7140BC1Q52909381-EDC1196B-7D0C-4844-90CB-E9C54B000151
P2860
Phosphoinositide 3-kinase signaling is critical for ErbB3-driven breast cancer cell motility and metastasis.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Phosphoinositide 3-kinase sign ...... cell motility and metastasis.
@ast
Phosphoinositide 3-kinase sign ...... cell motility and metastasis.
@en
type
label
Phosphoinositide 3-kinase sign ...... cell motility and metastasis.
@ast
Phosphoinositide 3-kinase sign ...... cell motility and metastasis.
@en
prefLabel
Phosphoinositide 3-kinase sign ...... cell motility and metastasis.
@ast
Phosphoinositide 3-kinase sign ...... cell motility and metastasis.
@en
P2093
P2860
P356
P1433
P1476
Phosphoinositide 3-kinase sign ...... cell motility and metastasis.
@en
P2093
A R Bresnick
J E Segall
J M Backer
J S Condeelis
P J Boimel
S J Coniglio
P2860
P2888
P304
P356
10.1038/ONC.2011.275
P407
P577
2011-07-04T00:00:00Z